Formulated for maximum bioavailability at 340 Daltons well below the 500 Da skin penetration threshold so the peptide actually reaches the fibroblast layer where collagen synthesis happens
ARSYNL Rx medical providers guide eligible patients on appropriate use based on their individualized plan
Prescription | E-prescription available
doi:10.1159/000053183 Heffernan M, Summers RJ, Thorburn A, et al
10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
When contract research companies decide what assets and capabilities to invest in, they should look at how clients' needs change over time and the therapeutic areas they focus on
